News - MedTech

Manchester spinout raises £1.8m to treat chronic diseases

Apini, a small molecule drug development programme being advanced by Syncona’s accelerator Slingsh...

MedTech given £860k Innovate UK grant to detect colorectal cancer

A biomarker discovery and diagnostics startup has been awarded £860,000 in funding from Innovate UK...

BioTech acquires Toronto-based Awakn

Clinical-stage BioTech Solvonis has acquired Toronto-based Awakn, expanding its research and develop...

BioTech CellCentric announces new chief financial officer

Cambridge-based BioTech CellCentric has appointed Celia Economides as its new chief financial office...

BioNTech unveils plan to invest £1bn in the UK

World-leading biopharmaceutical company BioNTech has announced a planned £1bn investment into the U...

AstraZeneca agrees £750m deal for EsoBiotec

AstraZeneca has agreed a deal to acquire EsoBiotec for up to £750m. The acquisition includes the...

CellCentric raises £90m to prevent cancer deaths

Cancer-fighting MedTech CellCentric has raised £90m in fresh funding. The Series C round will su...

Envoke raises further £1m after almost doubling ARR in last year

A UK company whose simulation software enables medical staff to train to use laboratory equipment an...

MedTech wins £1.26m Innovate UK grant to tackle brain tumours

A developer of an implanted electric field therapy (EFT) device for brain tumours has been awarded a...

Spotlight Pathology gets EHE backing for faster cancer diagnosis

A North West-based MedTech company developing AI-powered pathology tools has raised £425,000 in fun...

MedTech NCIMB raises £1.7m growth funding from IFS/Maven

Microbiology services provider NCIMB Limited has received £1.7m in investment to accelerate growth ...

IBEX raises £2m to target ‘silent disease’ osteoporosis

Bone health specialist IBEX innovations has closed a £2m funding round to fund the next phase in it...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.